Some states have mandated broader coverage
Tirzepatide holds FDA approvals as Mounjaro for type 2 diabetes (2022) and as Zepbound for chronic weight management (2023) and for moderate-to-severe obstructive sleep apnea (2024), and it is EMA-approved as well
The medial preoptic nucleus as a site of the thermogenic and metabolic actions of Melanotan II in male rats
X-ray fluorescence imaging of metals and metalloids in biological systems
However, we should not forget about an old one, pioglitazone, that can be used in combination with these newer antidiabetic, anti-obesity medications.
The compound's ability to restore tissue homeostasis and reverse age-related functional decline in animal models provides direct evidence for the role of senescent cells in aging processes, while its applications in cancer research offer insights into senescence mechanisms in disease progression and administration resistance